Get Full Government Meeting Transcripts, Videos, & Alerts Forever!
Senate committee hears testimony on HB 2387 to tighten rules and broaden clinical participation in Oregon psilocybin program
Summary
State lawmakers heard proponents describe House Bill 2387 as a technical “program improvement” bill for Oregon’s psilocybin services program, proposing confidentiality for investigations, clearer roles for licensed health professionals, new labeling requirements and collection of veteran status data.
The Senate Committee on Early Childhood and Behavioral Health opened a public hearing on House Bill 2387 on April 2025 to consider changes to the Oregon Psilocybin Services Program, sponsor State Representative Dacia Graber told the committee.
Rep. Dacia Graber, chief sponsor of HB 2387, said the bill makes “technical changes to the Oregon Psilocybin Services Program that are widely supported by the communities impacted and the service providers who deliver these critical mental health services.” She described provisions to allow health-care providers to discuss psilocybin with patients, require fingerprinting for license applications, and permit application denials after a failed criminal background check. “I encourage you as community leaders and as my colleagues to support these technical improvements,” Graber said.
The hearing included prepared testimony from program implementers and clinicians. Heidi Pendergast, Oregon director of the Healing Advocacy Fund, said HB 2387 would “ensure safety and access through technical program changes and bridges the gap between psilocybin services and behavioral health.” Pendergast summarized…
Already have an account? Log in
Subscribe to keep reading
Unlock the rest of this article — and every article on Citizen Portal.
- Unlimited articles
- AI-powered breakdowns of topics, speakers, decisions, and budgets
- Instant alerts when your location has a new meeting
- Follow topics and more locations
- 1,000 AI Insights / month, plus AI Chat
